Medivir AB (publ) (STO:MVIR)

Sweden · Delayed Price · Currency is SEK

1.604

-0.106 (-6.20%)

At close: Feb 27, 2026

Revenue by Segment

Financials in millions SEK. Fiscal year is January - December.

Millions SEK. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Pharmaceuticals	8.50M	3.48M	7.63M	4.41M	32.39M
Pharmaceuticals Growth	143.97%	-54.36%	73.16%	-86.39%	48.68%
Total	8.50M	3.48M	7.63M	4.41M	32.39M
Total Growth	143.97%	-54.36%	73.16%	-86.39%	48.68%

Revenue by Geography

Financials in millions SEK. Fiscal year is January - December.

Millions SEK. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Sweden	54.00K	192.00K	221.00K	216.00K
Sweden Growth	-71.88%	-13.12%	2.31%	390.91%
The Rest of The Nordic Countries	116.00K	186.00K	187.00K	318.00K
The Rest of The Nordic Countries Growth	-37.63%	-0.53%	-41.19%	-41.22%
The Rest of Europe	2.91M	3.31M	3.56M	3.66M
The Rest of Europe Growth	-12.10%	-7.16%	-2.70%	-55.64%
USA	-	3.58M	-	21.34M
USA Growth	-	-	-	317.65%
Elsewhere in The World	406.00K	367.00K	438.00K	-
Elsewhere in The World Growth	10.63%	-16.21%	-	-
Total	3.48M	7.63M	4.41M	25.54M
Total Growth	-54.38%	73.19%	-82.74%	83.09%

Source: S&P Global Market Intelligence.